sponsored
PatientsVille.com Logo

PatientsVille

Magnesium and Augmentin

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectMagnesiumAugmentin
DRUG HYPERSENSITIVITY0% 4%
DIARRHOEA3.1% 3.5%
NAUSEA3.4% 2.7%
FATIGUE3.3% 2.3%
PYREXIA1.8% 3%
DYSPNOEA2.5% 2.7%
DRUG INEFFECTIVE2.4% 1.6%
VOMITING2% 2.3%
HEADACHE2.2% 1.6%
RASH1.3% 2.2%
DIZZINESS2.2% 1.3%
PAIN2.1% 1.9%
ASTHENIA2.1% 1.7%
PNEUMONIA1.8% 2%
PRURITUS1.2% 1.9%
FALL1.8% 1%
MALAISE1.7% 1.5%
ANAEMIA1.4% 1.6%
ARTHRALGIA1.6% 1%
PAIN IN EXTREMITY1.4% 0.9%
HYPOTENSION1.2% 1.3%
ABDOMINAL PAIN1.2% 1.3%
INSOMNIA1.3% 0.8%
CONSTIPATION1.3% 0.8%
OFF LABEL USE1.3% 0.8%
ERYTHEMA0.6% 1.3%
SINUSITIS0.5% 1.3%
ANXIETY1.2% 1.2%
WEIGHT DECREASED1.2% 1.1%
COUGH1.1% 1.2%
ACUTE KIDNEY INJURY1% 1.2%
DEATH1.2% 1%
DRUG INTERACTION1% 1.2%
DECREASED APPETITE1.2% 0.9%
BACK PAIN1.2% 0.9%
RENAL FAILURE1.1% 0.9%
THROMBOCYTOPENIA0.7% 1.1%
MUSCLE SPASMS1.1% 0.5%
DEHYDRATION1% 1%
CHEST PAIN1% 0.9%
URINARY TRACT INFECTION1% 0.9%
DEPRESSION1% 0.8%
CONDITION AGGRAVATED1% 0.8%
RENAL FAILURE ACUTE0.6% 1%
GAIT DISTURBANCE1% 0.5%
URTICARIA0% 1%
CHOLESTASIS0% 1%
ABDOMINAL PAIN UPPER0.9% 0.9%
CONFUSIONAL STATE0.8% 0.9%
OEDEMA PERIPHERAL0.8% 0.9%
HYPERTENSION0.9% 0.8%
NEUTROPENIA0.5% 0.9%
FEELING ABNORMAL0.9% 0.5%
HEPATOCELLULAR INJURY0% 0.9%
WEIGHT INCREASED0.9% 0%
SEPSIS0.8% 0.8%
ATRIAL FIBRILLATION0.8% 0.7%
MYALGIA0.8% 0.6%
SOMNOLENCE0.8% 0.6%
HYPERSENSITIVITY0.5% 0.8%
PARAESTHESIA0.8% 0.5%
HAEMOGLOBIN DECREASED0.8% 0.5%
GENERAL PHYSICAL HEALTH DETERIORATION0% 0.8%
BRONCHITIS0% 0.8%
RASH MACULO-PAPULAR0% 0.8%
PLATELET COUNT DECREASED0.8% 0%
PULMONARY EMBOLISM0% 0.8%
JAUNDICE0% 0.8%
CHILLS0.6% 0.7%
HYPOAESTHESIA0.7% 0.5%
TREMOR0.7% 0%
INJURY0% 0.7%
CHRONIC KIDNEY DISEASE0.7% 0%
DEEP VEIN THROMBOSIS0% 0.7%
PANCYTOPENIA0% 0.7%
MUSCULAR WEAKNESS0.7% 0%
NEUROPATHY PERIPHERAL0.6% 0.6%
RESPIRATORY FAILURE0.6% 0.6%
LOSS OF CONSCIOUSNESS0.6% 0.5%
INFECTION0.5% 0.6%
ALANINE AMINOTRANSFERASE INCREASED0% 0.6%
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS0% 0.6%
CELLULITIS0% 0.6%
INTERNATIONAL NORMALISED RATIO INCREASED0% 0.6%
ASPARTATE AMINOTRANSFERASE INCREASED0% 0.6%
HEPATITIS0% 0.6%
PALPITATIONS0.6% 0%
PERIPHERAL SWELLING0.6% 0%
BLOOD CREATININE INCREASED0.6% 0%
DRUG DOSE OMISSION0.6% 0%
BLOOD PRESSURE INCREASED0.6% 0%
ALOPECIA0.6% 0%
ABDOMINAL DISTENSION0.6% 0%
NASOPHARYNGITIS0.6% 0%
GASTROINTESTINAL HAEMORRHAGE0.6% 0%
ABDOMINAL DISCOMFORT0.6% 0%
BLOOD GLUCOSE INCREASED0.6% 0%
RENAL IMPAIRMENT0.6% 0%
HYPONATRAEMIA0.6% 0%
MEMORY IMPAIRMENT0.6% 0%
WHITE BLOOD CELL COUNT DECREASED0.6% 0%
HYPERHIDROSIS0.5% 0.5%
DYSPHAGIA0.5% 0.5%
PLEURAL EFFUSION0.5% 0.5%
FEBRILE NEUTROPENIA0.5% 0.5%
CARDIAC FAILURE0.5% 0.5%
AGRANULOCYTOSIS0% 0.5%
OVERDOSE0% 0.5%
EMOTIONAL DISTRESS0% 0.5%
BLOOD ALKALINE PHOSPHATASE INCREASED0% 0.5%
TACHYCARDIA0% 0.5%
EOSINOPHILIA0% 0.5%
LEUKOPENIA0% 0.5%
EPISTAXIS0% 0.5%
CARDIAC ARREST0% 0.5%
HEPATITIS CHOLESTATIC0% 0.5%
UPPER RESPIRATORY TRACT INFECTION0% 0.5%
TOXIC SKIN ERUPTION0% 0.5%
CONTUSION0.5% 0%
ANAPHYLACTIC REACTION0% 0.5%
CARDIAC FAILURE CONGESTIVE0.5% 0%
GASTROOESOPHAGEAL REFLUX DISEASE0.5% 0%
VISION BLURRED0.5% 0%
MYOCARDIAL INFARCTION0.5% 0%
HEART RATE INCREASED0.5% 0%
CEREBROVASCULAR ACCIDENT0.5% 0%
FLUSHING0.5% 0%
SYNCOPE0.5% 0%
DYSPEPSIA0.5% 0%
INCORRECT DOSE ADMINISTERED0.5% 0%
INJECTION SITE PAIN0.5% 0%
TOXIC EPIDERMAL NECROLYSIS0% 0.5%

New treatments are found every day. View current Magnesium research studies and Augmentin clinical trials

1